Pharma channel feed – Endpoints News

Pharma channel feed

After an about-face on a PhIII trial, FDA sets up an adcomm to review controversial ALS drug next month

4 years ago

Benefits of Lilly's diabetes candidate tirzepatide aren't better than other diabetes drugs, says watchdog ICER

4 years ago

Court sides with Teva over Emergent in generic Narcan suit

4 years ago

Neil Young's Spotify protest puts Pfizer back in the crosshairs of vaccine conspiracy theories

4 years ago

Industry wants new European pharma makeover to increase the continent's attractiveness for R&D

4 years ago

Moderna’s once high-flying stock buckles under the weight of a biotech rout. Is it cheap yet?

4 years ago

Padcev gets a shot at another indication — for invasive bladder cancer — thanks to initial data readout

4 years ago

With FDA nods and third-shot OKs, Moderna and Pfizer boost vaccine ads – and booster messages

4 years ago

MarketingRx roundup: Super Bowl scores last minute ad from diagnostic; BBC spotlights AstraZeneca vaccine

4 years ago

From ‘functional’ to emotional, Amgen’s marketing for cancer bone med Xgeva shifts to patients’ stories

4 years ago

Mobile app developer adds disease-specific modules for patients – and pharma partners

4 years ago

GSK joins a crowd of pharma companies restricting sales under federal program

4 years ago

J&J defends talc bankruptcy gambit as plaintiffs mass in legal showdown

4 years ago

J&J’s Janssen suits up again for prostate cancer awareness at NY Fashion Week and Blue Jacket show

4 years ago

North American CDMO market poised for a boom to $8.65B by 2026 — report

4 years ago

Novartis is chopping 400 jobs in India after striking new distribution pact

4 years ago

Roivant reveals its newest 'vant,' trying to reboot an Eisai blood cancer program and outflank Merck, Bristol Myers

4 years ago

Market issues prey on potential bounceback for antibiotics, says a new report — here's how to fix it

4 years ago

Novo Nordisk wins over doctors with AI email subject lines — and a human touch

4 years ago

Appeals court quashes Sanofi’s big win on bellwether hair loss case

4 years ago

Trump administration insider Brett Giroir is taking the reins at a biotech startup

4 years ago

FTC plots a look into the competitive impact of PBMs on drug prices, pharmacies

4 years ago

Hunting more R&D deals, Ipsen is hammering out a $460M sale of consumer ops while cutting costs

4 years ago

Biogen slams coverage proposal for amyloid-targeted Alzheimer's drugs in 31-page comment

4 years ago

First page Previous page 222 223 224225226 227 228 Next page Last page